Philippe Chatellard

510 total citations
9 papers, 377 citations indexed

About

Philippe Chatellard is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Philippe Chatellard has authored 9 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Oncology. Recurrent topics in Philippe Chatellard's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Virus-based gene therapy research (3 papers) and Plant Gene Expression Analysis (2 papers). Philippe Chatellard is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Virus-based gene therapy research (3 papers) and Plant Gene Expression Analysis (2 papers). Philippe Chatellard collaborates with scholars based in Switzerland. Philippe Chatellard's co-authors include Florian Μ. Wurm, Markus O. Imhof, Nicolas Mermod, Horst Pick, Erhard Stutz, Michel Kobr, Monique Zahn‐Zabal, María De Jesús, Amparo Monfort and Anne Iten and has published in prestigious journals such as FEBS Letters, Biotechnology and Bioengineering and Plant Molecular Biology.

In The Last Decade

Philippe Chatellard

9 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Chatellard Switzerland 8 336 162 52 38 31 9 377
Kalavathy Sitaraman United States 7 281 0.8× 82 0.5× 59 1.1× 21 0.6× 19 0.6× 9 358
Martin S. Sinacore United States 9 321 1.0× 118 0.7× 67 1.3× 29 0.8× 40 1.3× 10 361
Yong Tao China 12 527 1.6× 68 0.4× 62 1.2× 39 1.0× 32 1.0× 25 644
J. Antonie Maassen Netherlands 11 486 1.4× 117 0.7× 45 0.9× 47 1.2× 12 0.4× 16 548
T Atkinson United Kingdom 8 344 1.0× 70 0.4× 81 1.6× 20 0.5× 14 0.5× 9 410
Heena Dhiman Austria 11 335 1.0× 124 0.8× 28 0.5× 29 0.8× 12 0.4× 19 366
Wolfgang Stiege Germany 13 749 2.2× 163 1.0× 74 1.4× 20 0.5× 25 0.8× 15 796
Régis Cèbe Switzerland 5 214 0.6× 60 0.4× 25 0.5× 18 0.5× 11 0.4× 6 313
Sharyn L. Rusch United States 13 329 1.0× 216 1.3× 25 0.5× 12 0.3× 25 0.8× 14 397
Christine Pampeno United States 12 212 0.6× 142 0.9× 24 0.5× 43 1.1× 10 0.3× 20 381

Countries citing papers authored by Philippe Chatellard

Since Specialization
Citations

This map shows the geographic impact of Philippe Chatellard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Chatellard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Chatellard more than expected).

Fields of papers citing papers by Philippe Chatellard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Chatellard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Chatellard. The network helps show where Philippe Chatellard may publish in the future.

Co-authorship network of co-authors of Philippe Chatellard

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Chatellard. A scholar is included among the top collaborators of Philippe Chatellard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Chatellard. Philippe Chatellard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chatellard, Philippe, et al.. (2006). The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells. Biotechnology and Bioengineering. 96(1). 106–117. 20 indexed citations
2.
Imhof, Markus O., Philippe Chatellard, & Nicolas Mermod. (2002). Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems. Journal of Biotechnology. 97(3). 275–285. 9 indexed citations
3.
Zahn‐Zabal, Monique, Michel Kobr, Markus O. Imhof, et al.. (2001). Development of stable cell lines for production or regulated expression using matrix attachment regions. Journal of Biotechnology. 87(1). 29–42. 101 indexed citations
4.
Pick, Horst, et al.. (2001). Transient gene expression: Recombinant protein production with suspension‐adapted HEK293‐EBNA cells. Biotechnology and Bioengineering. 75(2). 197–203. 146 indexed citations
5.
Imhof, Markus O., Philippe Chatellard, & Nicolas Mermod. (2000). A regulatory network for the efficient control of transgene expression. The Journal of Gene Medicine. 2(2). 107–116. 27 indexed citations
6.
Imhof, Markus O., Philippe Chatellard, & Nicolas Mermod. (2000). A regulatory network for the efficient control of transgene expression. The Journal of Gene Medicine. 2(2). 107–116. 2 indexed citations
7.
Chatellard, Philippe, Roland Sahli, Anne Iten, Jan von Overbeck, & Pascal Meylan. (1998). Single tube competitive PCR for quantitation of CMV DNA in the blood of HIV+ and solid organ transplant patients. Journal of Virological Methods. 71(2). 137–146. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026